Since joining Beasley Allen Law Firm in 2001, Roger has focused his practice on complex litigation involving pharmaceutical and medical devices in our Mass Torts Section, which is nationally recognized as a leader in drug litigation.
While at Beasley Allen, Roger’s leadership has resulted in the successful resolution of thousands of pharmaceutical cases. Roger served on the teams that negotiated the $4.85-billion Vioxx and the $2.4-billion Actos global settlements. Roger has also served as Lead Attorney in numerous cases where he has negotiated multi-million dollar settlements for our clients, including Rezulin, Serzone, Ephedra, PPA, herbal supplements, Gadolinium, Yaz/Yasmin, and Fleet Oral Phosphosoda.
Roger’s current focus includes defective DePuy Attune knee replacement claims, injuries resulting from the use of high viscosity bone cement in total knee replacement surgeries (requires early revision surgeries to correct mechanical loosening), claims on behalf of opioid users including addiction, overdose, and death, and injuries resulting from various herbal supplements.
Roger has served on numerous MDL committees and subcommittees and has served on an MDL Plaintiff Steering Committee.
Roger is licensed in Alabama, Mississippi, Arizona, Tennessee, Minnesota, Pennsylvania and West Virginia.
Awards and Ratings
Roger has been included in Best Lawyers since 2012 and was named to the 2018 Super Lawyers list. In 2015, he was named Beasley Allen Lawyer of the Year for the Mass Torts Section.
Roger received his Bachelor of Arts with honors from the University of Tennessee, Knoxville, and his Juris Doctor, cum laude, from the University of Alabama School of Law. Prior to joining Beasley Allen, Roger worked at defense firms in Phoenix, Arizona, and Knoxville, Tennessee, and at a publicly traded company as in-house counsel where he oversaw regulatory compliance.
Roger is married to Claudia C. Kennedy, of Vestavia Hills, Alabama. They have three children – Sarah Kennedy, Caroline and Sophie.